- Home
- ARE vs ALGN Comparison
ARE vs ALGN Comparison
Compare ARE & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARE
- ALGN
- Stock Information
- Founded
- ARE 1994
- ALGN 1997
- Country
- ARE United States
- ALGN United States
- Employees
- ARE N/A
- ALGN N/A
- Industry
- ARE Real Estate Investment Trusts
- ALGN Industrial Specialties
- Sector
- ARE Real Estate
- ALGN Health Care
- Exchange
- ARE Nasdaq
- ALGN Nasdaq
- Market Cap
- ARE 19.3B
- ALGN 16.5B
- IPO Year
- ARE 1997
- ALGN N/A
- Fundamental
- Price
- ARE $97.97
- ALGN $212.69
- Analyst Decision
- ARE Buy
- ALGN Hold
- Analyst Count
- ARE 11
- ALGN 10
- Target Price
- ARE $127.36
- ALGN $268.56
- AVG Volume (30 Days)
- ARE 1.3M
- ALGN 677.8K
- Earning Date
- ARE 01-27-2025
- ALGN 01-29-2025
- Dividend Yield
- ARE 5.39%
- ALGN N/A
- EPS Growth
- ARE 18.05
- ALGN 24.62
- EPS
- ARE 1.64
- ALGN 5.86
- Revenue
- ARE $3,085,452,000.00
- ALGN $3,960,519,000.00
- Revenue This Year
- ARE N/A
- ALGN $5.72
- Revenue Next Year
- ARE $2.15
- ALGN $6.12
- P/E Ratio
- ARE $59.54
- ALGN $36.27
- Revenue Growth
- ARE 10.21
- ALGN 4.03
- 52 Week Low
- ARE $97.93
- ALGN $196.09
- 52 Week High
- ARE $131.82
- ALGN $335.40
- Technical
- Relative Strength Index (RSI)
- ARE 29.30
- ALGN 36.43
- Support Level
- ARE $103.38
- ALGN $226.67
- Resistance Level
- ARE $103.97
- ALGN $246.19
- Average True Range (ATR)
- ARE 2.52
- ALGN 7.69
- MACD
- ARE -0.49
- ALGN -1.91
- Stochastic Oscillator
- ARE 0.37
- ALGN 0.56
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.